Designing a trial of early electrical stimulation to the stroke-affected arm: Qualitative findings on the barriers and facilitators.
Dawn-Marie Walker, Joanna Fletcher-Smith, Nikola Sprigg and 1 others
PMID 40337083WHAT IT FOUND
Therapists perceived time and lack of confidence as major barriers to early electrical stimulation, but patients confidently self-managed the treatment and found it acceptable.
Patients reported insufficient staff support due to ward pressures. This highlights a disconnect between clinician concerns and patient experience.
Key findings
01Therapists cited lack of confidence and knowledge as the primary barrier to delivering early electrical stimulation, often doubting electrode placement and fearing abnormal movement patterns.
02All patients in the intervention arm reported being able to confidently self-manage the electrical stimulation treatment at home, viewing the regimen as acceptable.
03Patients and carers reported a lack of staff support during hospitalization, attributing this to therapists being busy or unsure how to help, rather than the treatment itself being difficult.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study was conducted within the context of a feasibility trial, so participants had additional support and monitoring that might not be available in routine care. The prior relationship between one interviewer and the patients may have introduced bias, although the authors state no qualitative differences were found between interviewers. The sample size for qualitative analysis was relatively small (15 patients/carers, 16 therapists).
Declared interests
No conflicts of interest were declared in the provided text.
The easy way to misread this
Do not conclude that early electrical stimulation is ineffective or safe based on this paper. This study reports on the acceptability and feasibility of delivering the treatment, not its clinical efficacy or safety profile.